What is Inhibrx Biosciences, Inc.'s price / earnings?

Inhibrx Biosciences, Inc. (INBX) reported price / earnings of 0.1× in Q1 2025.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Inhibrx Biosciences, Inc. INBX Price / earnings

Price / earnings at other companies

PfizerPFE

14.7×—

Rogers CorporationROG

71.9×+39.4×

Merck & Co.MRK

33.3×+20.3×

Gilead SciencesGILD

18.8×-4.6×

Jazz PharmaceuticalsJAZZ

15.6×-7.1×

IncyteINCY

13.1×-538×

Other financials

Income statement

See full

Revenue--100%

Operating income-$30.9M+27.9%

Net income-$33.4M+22.8%

EPS (diluted)-$2.15+23.2%

Balance sheet

See full

Cash & equivalents$161.7M-25.3%

Total debt$180.9M+69.8%

Total equity-$21.0M-122%

Total assets$184.0M-24.2%

Cash flow

See full

Operating cash flow-$38.0M-5.9%

CapEx--100%

Free cash flow-$38.0M-5.9%

Valuation

See full

Market cap$1.52B+474%

Enterprise value$1.54B+730%

Profitability

See full

Operating margin-10,386.5%-5,025pp

Net margin-10,773.5%-878,492pp

FCF margin-9,986.5%-4,727pp

Returns & leverage

See full

Return on equity-197.8%-2,158pp

Debt / equity13.4×+13.3×

Current ratio6.5×+1.3×

Where this comes from

Calculated from Inhibrx Biosciences, Inc.’s reported figures.

market cap/net income=0.1×

Based on the most recent quarter.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s price / earnings?: Inhibrx Biosciences, Inc. (INBX) reported price / earnings of 0.1× in Q1 2025.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.